Turnover among scientists at biotechnology companies remains high as this budding industry continues to spawn new ventures that allow personnel to shift jobs easily, according to a recent study conducted by the Emlyn Group, a human-resources consulting firm.

Last year, the San Diego-based Emlyn Group surveyed 250 biotechnology companies in the United States and Canada and received responses from 23 firms. The results of the study were released earlier this year.

Of the companies responding to the survey, 82.6 percent are independently owned firms and 56.5 percent are privately held. About 61 percent specialize in pharmaceuticals, and 26 percent focus on diagnostics. Some 17.4 percent supply equipment or materials, while 4.3 percent are in bioagriculture, including pesticides and vegetables. Software firms constituted 4.3 percent of the respondents. On average, the companies employ 140 people. About half (51.4 percent) of these employees are engaged in research, product development, quality assurance, manufac-...

Interested in reading more?

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?